Irish based pharma companies exported a whopping €13.7bn worth of goods in the month of May alone. .  The pharma sector is not yet paying 15% tariffs on all exports to the US but that looks like it will be the max once the famous section 232 investigation is sorted. But what will these tariffs mean in the long run for those American pharma giants such as Ely Lily and Pfizer who have been here for years but are under pressure to shift production back to the States?  

All to discuss with Oliver O'Connor, is the chief executive of the Irish Pharmaceutical Healthcare Association.